Investitionsthese
Novalis Biotech focuses on capital-light platform technology and close interaction with customers to support the development of innovative healthcare concepts from the state of incorporation.
Investitionsphase
Early-stage startups, from (pre-)seed stage to Series A
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Enabling technologies in life sciences, including innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, and digital health
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
k.A.
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (9)
B
Bart Rossel
Advisory board member
C
Cedric Bogaert
Entrepreneur in Residence - managing myNEO
J
Jan Berghe
Managing Director & Co-Founder
J
Jan Van den Berghe
Co-founder / Managing Director
J
Jaroslav Belotserkovsky
Investment Manager
K
Kathleen Van den Berghe
Member of the Supervisory Board
L
Liesbeth Ceelen
Advisory board member
M
Michael Hengartner
Advisory board member
W
Wim Van Criekinge
Co-founder / Managing Director
